![Elizabeth Masson-Hurlburt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Elizabeth Masson-Hurlburt is currently EVP, Chief Operating & Integration Officer at CorMedix, Inc., a position starting in 2025.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes undergraduate studies at Bay Path College and graduate studies at Western Governors University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CORMEDIX INC. 0,36 % | 04/02/2026 | 278.539 ( 0,36 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CORMEDIX INC. | Director de Operaciones | - |
| Empresas | Cargo | Fin |
|---|---|---|
| METAVIA INC. | Director Técnico/Científico/I+D | 01/03/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Bay Path College
 Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Governors University
 Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
